|
US6319685B1
(en)
|
1984-09-27 |
2001-11-20 |
Unigene Laboratories, Inc. |
Alpha-amidating enzyme compositions and processes for their production and use
|
|
US4708934A
(en)
|
1984-09-27 |
1987-11-24 |
Unigene Laboratories, Inc. |
α-amidation enzyme
|
|
US5789234A
(en)
|
1987-08-14 |
1998-08-04 |
Unigene Laboratories, Inc. |
Expression systems for amidating enzyme
|
|
US5102666A
(en)
|
1990-09-11 |
1992-04-07 |
Oramed, Inc. |
Calcium polycarbophil controlled release composition and method
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US6692766B1
(en)
|
1994-06-15 |
2004-02-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Controlled release oral drug delivery system
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
WO1998046722A1
(en)
|
1997-04-16 |
1998-10-22 |
Unigene Laboratories Inc. |
Direct expression of peptides into culture media
|
|
JP2002531518A
(ja)
|
1998-12-04 |
2002-09-24 |
プロヴァリス・ユーケー・リミテッド |
インスリン含有医薬組成物
|
|
ES2235854T3
(es)
|
1999-04-05 |
2005-07-16 |
Emisphere Technologies, Inc. |
Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos.
|
|
US6780846B1
(en)
|
1999-09-27 |
2004-08-24 |
Elan Corporation, Plc |
Membrane translocating peptide drug delivery system
|
|
GB2368792A
(en)
|
2000-10-06 |
2002-05-15 |
Roger Randal Charles New |
Absorption enhancers
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
WO2005004792A2
(en)
*
|
2003-06-24 |
2005-01-20 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
ES2665464T3
(es)
|
2003-03-28 |
2018-04-25 |
Sigmoid Pharma Limited |
Forma de dosificación oral sólida que contiene microcápsulas sin costuras
|
|
GB0308732D0
(en)
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
|
ES2398237T3
(es)
|
2003-07-23 |
2013-03-14 |
Novartis Ag |
Uso de calcitonina en osteoartritis
|
|
US20070172517A1
(en)
|
2003-09-17 |
2007-07-26 |
Ben-Sasson Shmuel A |
Compositions capable of facilitation penetration across a biological barrier
|
|
AU2005263729B2
(en)
|
2004-07-22 |
2011-01-06 |
Bey Pharma GmbH |
Use of compounds containing thiol groups as an efflux pump inhibitor
|
|
US7445911B2
(en)
|
2004-11-24 |
2008-11-04 |
Unigene Laboratories Inc. |
Enzymatic reactions in the presence of keto acids
|
|
AU2006261909B2
(en)
|
2005-06-24 |
2011-08-11 |
Enteris Biopharma, Inc. |
Cell lines for expressing enzyme useful in the preparation of amidated products
|
|
WO2007029238A2
(en)
|
2005-09-06 |
2007-03-15 |
Oramed Pharmaceuticals, Inc. |
Methods and compositions for oral administration of proteins
|
|
US8093207B2
(en)
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
EP1834635B1
(en)
|
2006-03-13 |
2011-07-06 |
Advanced in Vitro Cell Technologies, S.L. |
Stable nanocapsule systems for the administration of active molecules
|
|
BRPI0710503A2
(pt)
|
2006-04-07 |
2011-08-16 |
Merrion Res Iii Ltd |
uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
|
|
US8377863B2
(en)
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
|
US8962015B2
(en)
|
2007-09-28 |
2015-02-24 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
CA2755068C
(en)
*
|
2009-03-12 |
2018-11-06 |
Keybioscience Ag |
Treatment of diabetes and metabolic syndrome
|
|
EP2493919A1
(en)
*
|
2009-10-30 |
2012-09-05 |
Novo Nordisk A/S |
Derivatives of cgrp
|
|
JP6039569B2
(ja)
*
|
2010-11-09 |
2016-12-07 |
ノヴォ ノルディスク アー／エス |
二重アシル化されたｇｌｐ−１誘導体
|
|
US9533022B2
(en)
*
|
2011-11-02 |
2017-01-03 |
KeyBioscience A/S |
Peptide analogs for treating diseases and disorders
|
|
EP3357540A1
(en)
*
|
2011-11-02 |
2018-08-08 |
KeyBioscience AG |
Combination of calcitonin mimetic and insulin sensitizer
|
|
US9006172B2
(en)
*
|
2011-11-02 |
2015-04-14 |
Keybioscience Ag |
Peptide analogs for treating diseases and disorders
|
|
CN105722854B
(zh)
|
2013-11-14 |
2020-08-04 |
关键生物科学有限公司 |
用于治疗疾病和病症的降钙素模拟物
|
|
GB201500263D0
(en)
*
|
2015-01-08 |
2015-02-25 |
Keybioscience Ag |
Calcitonin analogues for treating diseases and disorders
|
|
JP2018529749A
(ja)
*
|
2015-10-07 |
2018-10-11 |
シプルメット・ゲーエムベーハー |
ペプチド薬物を経口送達するための医薬製剤
|
|
JP2019517523A
(ja)
*
|
2016-06-03 |
2019-06-24 |
ケモセントリックス， インコーポレイテッド |
肝線維症を治療する方法
|